Skip to main content
You have permission to edit this video.
Edit
AP

FDA panel reviews Pfizer's COVID vaccine for kids

From the Watch Now: Nor'easter floods roads in New York City, and more of today's top videos series
  • Updated
  • 0

U.S. health advisers are deliberating whether kid-size doses of Pfizer's COVID-19 vaccine are safe and effective for 5- to 11-year-olds. Tuesday's meeting of the Food and Drug Administration panel is the first step toward expanding vaccinations to 28 million young children.

0 Comments

Get up-to-the-minute news sent straight to your device.

Topics

News Alerts

Breaking News